Anisha Patel, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Astellas Pharma US, Inc
    Date added:
    10/20/2026
    Date updated:
    10/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Asymmetric Therapeutics, LLC
    Date added:
    10/20/2026
    Date updated:
    10/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Deciphera Pharmaceuticals, Inc.
    Date added:
    10/20/2026
    Date updated:
    10/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    EMD Serono
    Date added:
    10/20/2026
    Date updated:
    10/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Erasca
    Date added:
    10/20/2026
    Date updated:
    10/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    FBIO Acquisition Corp LXI
    Date added:
    10/20/2026
    Date updated:
    10/20/2026
  • Attribution:
    Other
    Type of financial relationship:
    Researcher
    Ineligible company:
    Hoth Therapeutics
    Date added:
    10/20/2026
    Date updated:
    10/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Ideology Health
    Date added:
    10/20/2026
    Date updated:
    10/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Janssen Scientific Affairs, LLC
    Date added:
    10/20/2026
    Date updated:
    10/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Lutris
    Date added:
    10/20/2026
    Date updated:
    10/20/2026

Pages

Return to Treatment Options for Vitiligo: A review of Current and Future Therapies